Prince Edward Island announces new biosimilar exchange policy
The Government of Prince Edward Island (PEI) has become the eleventh Canadian jurisdiction to implement a biosimilar switch or transition policy, according to a statement from Biosimilars Canada. The policy will require patients enrolled in the PEI Pharmacare program who are taking certain reference biologics to transition to a biosimilar version (Table). Additionally, all new … Read more